World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12614001188628
Date of registration: 12/11/2014
Prospective Registration: Yes
Primary sponsor: Poznan University of Medical Sciences
Public title: Trigger point related vasomotor response to dry needling in patients with low back pain referred to the leg and healthy volunteers
Scientific title: For trigger points (TrPs) positive low back pain referred to the leg patients and TrPs-positive healthy volunteers as compared to TrPs-negative low back pain referred to the leg patients and TrPs-negative healthy volunteers, will dry needling provoke vasomotor reactions in the pain area and, thus, confirm the influence of sympathetic nerve activity on trigger point pain propagation.
Date of first enrolment: 20/11/2014
Target sample size: 70
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12614001188628.aspx
Study type:  Interventional
Study design:  Purpose: Diagnosis; Allocation: Non-randomised trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Poland
Contacts
Name: Dr Elzbieta Skorupska   
Address:  Poznan University of Medical Sciences Fredry 10 61-701 Poznan Poland
Telephone: +48694398333
Email: skorupska@interia.pl
Affiliation: 
Name: Dr Elzbieta Skorupska   
Address:  Poznan University of Medical Sciences Fredry 10 61-701 Poznan Poland
Telephone: +48 694 398 333
Email: skorupska@interia.pl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Experimental group
Key inclusion criteria: low back pain radiating down, age between 20 and 60 (inclusive), both lower limbs present, pain duration >3 months, >3 on the 1-10 point VAS scale;leg pain, with this being the dominant pain problem.

Healthy volunteers
Key inclusion criteria: general good health condition, age between 20 and 60 (inclusive), both lower limbs present

Exclusion criteria: Experimental group

Key exclusion criteria: complex regional pain syndrome, cauda equina syndrome, previous back surgery, spinal tumors, scoliosis, pregnancy, coagulant treatment, disseminated intravascular coagulation, diabetes, epilepsy, infection, inflammatory rheumatologic diseases, stroke, or oncological history.

Healthy volunteers

Key exclusion criteria: previous back surgery, spinal tumors, scoliosis, pregnancy.


Age minimum: 20 Years
Age maximum: 60 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Physical Medicine / Rehabilitation - Physiotherapy
Musculoskeletal - Other muscular and skeletal disorders
Neurological - Other neurological disorders
low back pain reffered to leg;
low back pain reffered to leg
Intervention(s)
Forty chronic low back pain radiating down patients (experimental group) will be recruited to the study from Poznan GP doctors and the University Pain Clinic. Thirty healthy volunteers will be recruited by press announcement.
Experimental group will be examined towards TrPs presence within the gluteus minimus. After that subjects will be assigned to four groups; group I: TrPs-positive experimental (n=20), group II: TrPs-negative experimental (n=20), group III: TrPs-negative control (n=15), and group IV: TrPs-positive control (n=15).
Each of the participants will draw his/her pain on a diagram and define the pain on the visual analogue scale (VAS).
Before the Infrared Thermovision camera (IRT) session, the presence of active TrPs for experimental and control within the gluteus minimus muscle will be re-examined. After that IRT side-to-side comparison of the lower limb will be performed and then all participants will receive the dry needling (DN) session (2x 5 minutes with the 30 second break) and post-dry needling observation at rest (six consecutive minutes) under IRT control. DN will be performed within the gluteus minimus muscle into: two TrPs (group I and group IV) or two the most tender points (group II and group III). The area to be observed by IRT will be chosen according to the gluteus minimus referred pain pattern. Additionally, during DN participants will be asked to report the area of referred pain (thigh, calf, foot). The participants and IRT camera operator will not be aware of the myofascial pain diagnosis results. During IRT, the dry needling specialist will not be aware of the IRT camera results.
The dry needling under IRT control will be conducted once.
Diagnostic criteria of active TrPs for experimental group: active TrPs will be co
Primary Outcome(s)
Skin temperature response to dry needling under IRT control of TrPs-positive low back pain radiating down subjects and TrPs-positive healthy volounteers[Baseline, as well as 5 and 10 minutes of DN and six minutes of IRT observations post-DN]
Vasomotor response to dry needling under infrared thermovision camera control of non-TrPs low back pain radiating down subjects and TrPs-positive healthy volunteers (if present)[Baseline, as well as 5 and 10 minutes of DN and six minutes of IRT observations post-DN]
Secondary Outcome(s)
Size evaluation of vasomotor response to dry needling under infrared thermovision camera control regarding the presence of active, latent, likely TrPs[Baseline, as well as 5 and 10 minutes of DN and six minutes of IRT observations post-DN]
Skin temperature response to dry needling under IRT control regarding the presence of active, latent, likely TrPs [Baseline, as well as 5 and 10 minutes of DN and six minutes of IRT observations post-DN]
Secondary ID(s)
None
Source(s) of Monetary Support
Poznan University of Medical Sciences
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Ethics Committee of Poznan University of Medical Sciences
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history